ArticleDrug design, development and therapy2015

Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach.

Shu-Ting Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.